WallStreetZenWallStreetZen

NASDAQ: LXRX
Lexicon Pharmaceuticals Inc Stock Ownership - Who owns Lexicon Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Lexicon Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Invus Global Management LLCDirector2026-02-021,538,462$1.30
$2.00MBuy
Invus Global Management LLCDirector2026-02-02367,145$65.00
$23.86MBuy
Invus Global Management LLCDirector2026-02-0218,553,846$1.30
$24.12MBuy
Invus Global Management LLCDirector2026-02-023,846,154$1.30
$5.00MBuy
Alan J. MainEVP Innov Chem Sciences2025-02-2843,434$0.67
$29.10kSell
Kristen AlexanderVP Finance and Accounting2025-02-2817,862$0.67
$11.97kSell
Wendy McDermottSVP Human Resources2025-02-2830,004$0.67
$20.10kSell
Brian T. CrumSVP General Counsel Secr.2025-02-2845,622$0.67
$30.57kSell
Lisa DefrancescoSVP IR and Corp Comm2025-02-289,096$0.67
$6.09kSell
Craig B. GranowitzSVP Chief Medical Officer2025-02-2865,308$0.67
$43.76kSell

1 of 1

LXRX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when LXRX insiders and whales buy or sell their stock.

LXRX Shareholders

What type of owners hold Lexicon Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
International Sca Artal87.66%318,557,433$436.42MInsider
Raymond Debbane85.37%310,221,563$425.00MInsider
Participations Sa Rl Artal37.47%136,180,481$186.57MInsider
Artal Group Sa37.47%136,180,481$186.57MInstitution
Siren LLC10.71%38,918,903$53.32MInstitution
Fmr LLC10.64%38,679,748$52.99MInstitution
Invus Public Equities LP9.74%35,402,689$48.50MInsider
Siren LLC9.74%35,402,689$48.50MInsider
Amaury Wittouck9.74%35,402,689$48.50MInsider
Cv Invus8.32%30,248,505$41.44MInsider

1 of 3

LXRX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
LXRX21.59%78.41%Net BuyingNet Buying
PRTA49.89%50.11%Net Selling
ALT39.54%60.46%Net SellingNet Selling
SLDB55.25%44.75%Net BuyingNet Selling
ZVRA70.82%22.75%Net SellingNet Selling
View Top Biotech Stocks

Lexicon Pharmaceuticals Stock Ownership FAQ

Who owns Lexicon Pharmaceuticals?

Lexicon Pharmaceuticals (NASDAQ: LXRX) is owned by 70.21% institutional shareholders, 254.91% Lexicon Pharmaceuticals insiders, and 0.00% retail investors. International Sca Artal is the largest individual Lexicon Pharmaceuticals shareholder, owning 318.56M shares representing 87.66% of the company. International Sca Artal's Lexicon Pharmaceuticals shares are currently valued at $417.31M.

If you're new to stock investing, here's how to buy Lexicon Pharmaceuticals stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.